Rocket Pharmaceuticals, Inc. (RCKT)

Last Three Months

01-Jan-23 -- 31-Mar-23

Time Period:

Three Months
|
Year

($323.92K) Net Amount

Buy:	0	--
Sell:	($323.92K)	$19.06

Company Sentiment

Biotechnology

Drugs

Sentiment Breakdown by Insider

1

(3)

0

(2)

0

(1)

18

0

0

+1

0

+2

0

+3

Two Year Chart

01-Apr-21 -- 31-Mar-23

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
22-Feb-23 7:28 PM View:	17-Feb-23 Market Sale ($23.71K)	Militello John See Remarks		Rocket Pharmaceuticals, Inc. - RCKT	(44%) 2.86K to 1.61K	0	($23.71K) (44%)	--	$19.06	Show Txns Hide Txns

22-Feb-23 7:27 PM View:	17-Feb-23 Market Sale ($232.42K)	Shah Gaurav CEO Director		Rocket Pharmaceuticals, Inc. - RCKT	(2%) 549.08K to 536.88K	0	($232.42K) (2%)	--	$19.06	Show Txns Hide Txns

22-Feb-23 7:28 PM View:	17-Feb-23 Market Sale ($67.80K)	Schwartz Jonathan David See Remarks		Rocket Pharmaceuticals, Inc. - RCKT	(4%) 98.1K to 94.55K	0	($67.80K) (4%)	--	$19.06	Show Txns Hide Txns